Investigational New Drugs

Preface: New Therapeutic Strategies for Prostate Cancer: Reasons for Optimism and Reflection

Anthony W. Tolcher

Targeting Anti-Apoptotic Genes Upregulated by Androgen Withdrawal Using Antisense Oligonucleotides to Enhance Androgen- and Chemo-Sensitivity in Prostate Cancer

Martin E. Gleave, Toby Zellweger, Kim Chi, Hideaki Miyake, Satoshi Kiyama, Laura July, Simon Leung

Signaling Inhibitors in the Treatment of Prostate Cancer

Gary R. Hudes

Endothelin-1 as a Target for Therapeutic Intervention in Prostate Cancer

E. Scott Kopetz, Joel B. Nelson, Michael A. Carducci

Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer

William D. Figg, Erwin A. Kruger, Douglas K. Price, Sonia Kim, William D. Dahut

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ as a Novel Target for Prostate Cancer

Matthew R. Smith, Philip W. Kantoff

New Trial Designs to Assess Antitumor and Antiproliferative Agents in Prostate Cancer

Walter Stadler

Suramin's Development: What Did we Learn?

Maninderjeet Kaur, Eddie Reed, Oliver Sartor, William Dahut, William D. Figg

Announcement: Call for Mesothelioma Therapy Research Grant Applications

Instructions for Authors